Drug Shortage Report for APO-LENALIDOMIDE
| Report ID | 207695 |
| Drug Identification Number | 02507978 |
| Brand name | APO-LENALIDOMIDE |
| Common or Proper name | LENALIDOMIDE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LENALIDOMIDE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 21 BLS |
| ATC code | L04AX |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-16 |
| Estimated end date | 2023-12-01 |
| Actual end date | 2023-11-30 |
| Shortage status | Resolved |
| Updated date | 2023-12-01 |
| Company comments | Inventory shortage avoided |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2023-12-01 | French | Compare |
| v12 | 2023-12-01 | English | Compare |
| v11 | 2023-12-01 | French | Compare |
| v10 | 2023-12-01 | English | Compare |
| v9 | 2023-12-01 | English | Compare |
| v8 | 2023-11-24 | French | Compare |
| v7 | 2023-11-24 | English | Compare |
| v6 | 2023-11-24 | French | Compare |
| v5 | 2023-11-24 | English | Compare |
| v4 | 2023-11-17 | French | Compare |
| v3 | 2023-11-17 | English | Compare |
| v2 | 2023-10-20 | French | Compare |
| v1 | 2023-10-20 | English | Compare |
Showing 1 to 13 of 13